Open the mobile version, with barcode scanning
Class II Terminated

Theophylline (Anhydrous) Extended-Release Tablets, 400 mg, 100-count bottle, Rx Only, Manufactured by: Nostrum Laboratories, Inc., Kansas City, MO 64120, NDC 29033-001-01.

Why: CGMP Deviations: poor manufacturing practices resulted in Labeling: Incorrect or Missing Lot and/or Exp Date, product incorrectly labeled with incorrect lot and expiration date.

Company
Nostrum Laboratories Inc
Kansas City, MO, United States
Reported
Apr 1, 2020
Recall started
Mar 6, 2020
Ended
Apr 1, 2022
Where sold
TN, MO
Amount
4722 bottles
Full product description
Theophylline (Anhydrous) Extended-Release Tablets, 400 mg, 100-count bottle, Rx Only, Manufactured by: Nostrum Laboratories, Inc., Kansas City, MO 64120, NDC 29033-001-01.
Lots / codes affected
Lot: THE190501, Exp 11/2022

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.